Wantong Medical Releases 2025 ESG Report, Chinese Innovation Empowers Global Healthcare Accessibility

Source: Jinzong Technology

On March 26, 2026, Wandong Medical (600055.SH) officially released the “2025 Environmental, Social, and Governance (ESG) Report,” comprehensively disclosing the company’s systematic practices in technological innovation, medical accessibility, green low-carbon initiatives, and compliant governance. In 2025, Wandong Medical drove high-end technological leaps with the theme of “AI Full-Dimensional Intelligent Transformation,” continuously expanding the boundaries of medical services, achieving deep integration of corporate operational value with social and environmental benefits.

Technological Innovation: Driving High-End Imaging Technology Breakthroughs with “Independent Chips”

Wandong Medical always regards independent innovation as the core of development, leading the national key R&D project during the 14th Five-Year Plan—“Research and Development of Non-Contact Cardiovascular Magnetic Resonance Gating System and Prototype”—as well as the Ministry of Industry and Information Technology’s medical device material production and application demonstration platform, collaborating with renowned universities and medical institutions to tackle technical challenges. Several of the company’s practical achievements have been included in the “National High-End Medical Equipment Promotion and Application Directory,” and awarded the Beijing Science and Technology Progress First Prize.

Guided by the “AI Full-Dimensional Intelligent Transformation,” the company has achieved technological upgrades across the entire chain. The third-generation liquid helium-free superconducting MRI system has completely eliminated dependence on liquid helium resources, with a core component自主率 of 100%; the TwinStar AI 80M MRI has achieved a breakthrough in global technological gap, innovatively enabling simultaneous quantitative imaging of dual perfusion scans; the new DSA product series CGO-5200, equipped with the world’s first rare-earth IGZO detector, uses自主可控 (“independent and controllable”) “Chinese chips” to redefine high-end vascular imaging standards. The company’s subsidiary Wanli Cloud has launched a domestically自主知识产权 (“independent intellectual property rights”) “Medical Imaging Multimodal Intelligent Diagnostic Large Model,” solidifying the technological foundation of domestic high-end medical equipment. In 2025, the company promoted comprehensive upgrades in intelligent manufacturing, with the Beijing R&D intelligent manufacturing base officially operational, establishing a digital intelligent manufacturing benchmark in the field of domestic medical imaging equipment.

Empowering Globally: Expanding Medical Service Boundaries with Chinese Solutions

While strengthening technological foundations, Wandong Medical continues to promote the sinking of high-quality medical resources and global expansion. In 2025, the company actively responded to the construction of county-level medical共同体 (“medical community”), implementing six empowerment plans including information platforms, talent training, and discipline development. Wanli Cloud has served over 80 million people, with an AI daily call volume exceeding 20k; utilizing 5G remote diagnosis networks, it invited imaging experts from top-tier hospitals nationwide to conduct online mentorship for grassroots doctors, training over 10,000 grassroots imaging physicians; a one-stop interventional solution has covered more than 140 counties, assisting in over 100k interventional surgeries, supporting “big diseases without leaving the county.”

The company continues to promote Chinese制造 (“manufacturing”) going global, implementing the “5+1” regional strategy, with products and services covering over 110 countries and regions worldwide. At the 2025 European Congress of Radiology (ECR), the company announced strategic cooperation with VMI Group of Brazil for localized研发布局 (“research and development layout”). The liquid helium-free superconducting MRI has been installed in nearly 20 countries, with DR equipment surpassing 700 units in Europe, covering key markets such as Eastern and Southern Europe, and achieving large-scale application in multiple countries.

Green Transformation: Practicing Low-Carbon Commitments Throughout the “Lifecycle”

Wandong Medical integrates the “dual carbon” goals into its entire operation chain, embedding green development concepts throughout the lifecycle to build a green ecological closed loop. In source design, the company established an eco-design management system covering the entire process, setting core indicators such as拆卸率 (“disassembly rate”) over 85% and可回收利用率 (“recyclability”) over 90%; in technological carbon reduction, the third-generation liquid helium-free superconducting MRI system addresses the dependency on liquid helium resources from the source, achieving “zero liquid helium loss, zero site restrictions, zero liquid helium disturbance,” significantly lowering installation barriers and lifecycle costs; the company strictly enforces restrictions on hazardous substances and prioritizes renewable, low environmental impact materials; it has developed digital cloud-based film services, fully replacing traditional medical films and paper reports, promoting green transformation in medical service links.

In supply chain collaboration, the company has built a multi-dimensional ESG evaluation system for suppliers, using digital means to promote decarbonization across the entire supply chain, advocating green packaging materials and refined warehousing management, utilizing digital tools to achieve full-chain decarbonization and efficiency.

Compliance Governance: Ensuring High-Quality Development with a “Steady Foundation”

Wandong Medical always regards legal compliance as the foundation of corporate operation, building a solid safety and development barrier. In quality control, the company has established a comprehensive quality management system covering the entire product lifecycle, with a product pass rate of 100% in 2025, no safety production责任事故 (“responsibility accidents”) for ten consecutive years, 100% quality review pass rate by regulatory agencies, no product recalls throughout the year, customer satisfaction reaching 95%, and earning a “Five-Star” after-sales service certification.

Upholding a people-oriented development philosophy, the company fully safeguards employees’ legal rights, achieving 100% coverage in labor contract signing, social insurance and housing fund, and occupational disease hazard health examinations. Additionally, it further improves talent development and incentive mechanisms through stock option plans and multi-level training, continuously stimulating organizational vitality.

The company practices the “Healthy China” strategy, collaborating with hospitals and experts to implement the “Chinese Backbone Guardian Program,” reducing radiation doses by 50% through自主研发 (“independent R&D”) full-field DR imaging, hosting multiple campaigns in schools and hospitals to promote the “Chinese Backbone Guardian Program,” providing free screenings for children in various regions.

Looking ahead, Wandong Medical will leverage more突破性的 (“breakthrough”) technological innovations and more systematic ESG practices to support the high-quality development of China’s medical imaging industry and contribute Chinese wisdom to global healthcare.

Disclaimer: The release of this content aims to disseminate more information for reference only, not as a basis for trading, and readers should verify relevant content independently.

Special Statement: The above content only represents the author’s personal views or positions and does not reflect Sina Finance Headlines’ opinions or stances. If there are any issues related to the content, copyright, or others requiring contact, please do so within 30 days of the content’s publication.